Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00004184
Recruitment Status : Completed
First Posted : September 16, 2004
Last Update Posted : April 12, 2013
National Cancer Institute (NCI)
Information provided by:
University of Alabama at Birmingham

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : June 2001
  Study Completion Date : June 2001